Astera Labs (NASDAQ:ALAB) Updates Q1 2025 Earnings Guidance

Astera Labs (NASDAQ:ALAB - Get Free Report) issued an update on its first quarter 2025 earnings guidance on Monday morning. The company provided earnings per share guidance of 0.280-0.290 for the period, compared to the consensus earnings per share estimate of 0.250. The company issued revenue guidance of $151.0 million-$155.0 million, compared to the consensus revenue estimate of $133.9 million.

Astera Labs Stock Performance

ALAB traded up $0.69 on Thursday, hitting $88.19. 6,127,745 shares of the company were exchanged, compared to its average volume of 5,548,214. The stock's fifty day moving average is $121.35 and its 200-day moving average is $82.90. Astera Labs has a 12 month low of $36.22 and a 12 month high of $147.39.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings data on Monday, February 10th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. As a group, sell-side analysts expect that Astera Labs will post -0.45 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on ALAB. Roth Mkm lifted their price target on Astera Labs from $80.00 to $105.00 and gave the stock a "buy" rating in a report on Tuesday, November 5th. Barclays boosted their price target on Astera Labs from $87.00 to $135.00 and gave the company an "overweight" rating in a research note on Friday, January 17th. Morgan Stanley dropped their target price on Astera Labs from $142.00 to $114.00 and set an "equal weight" rating for the company in a report on Tuesday, January 28th. Citigroup started coverage on shares of Astera Labs in a research note on Monday, November 18th. They issued a "buy" rating and a $120.00 price target on the stock. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Astera Labs from $70.00 to $110.00 and gave the stock an "overweight" rating in a research note on Tuesday, November 5th. One investment analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of $115.33.

Insider Activity at Astera Labs

In related news, CFO Michael Truett Tate sold 7,398 shares of the company's stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $90.81, for a total transaction of $671,812.38. Following the transaction, the chief financial officer now directly owns 286,424 shares of the company's stock, valued at approximately $26,010,163.44. This represents a 2.52 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Stefan A. Dyckerhoff sold 197,297 shares of the business's stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $90.51, for a total value of $17,857,351.47. Following the sale, the director now owns 6,148 shares of the company's stock, valued at approximately $556,455.48. This represents a 96.98 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 846,452 shares of company stock worth $86,427,256 over the last ninety days.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.